Your browser doesn't support javascript.
loading
Serotonin transporter binding and anxiety symptoms in Parkinson's disease.
Joling, Merijn; van den Heuvel, Odile A; Berendse, Henk W; Booij, Jan; Vriend, Chris.
Afiliação
  • Joling M; Department of Neurology, VU University Medical Center, Amsterdam, The Netherlands.
  • van den Heuvel OA; Department of Nuclear Medicine, Academic Medical Center, Amsterdam, The Netherlands.
  • Berendse HW; Research Program Neurodegeneration, Amsterdam Neuroscience, Amsterdam, The Netherlands.
  • Booij J; Department of Anatomy and Neurosciences, VU University Medical Center, Amsterdam, The Netherlands.
  • Vriend C; Research Program Neurodegeneration, Amsterdam Neuroscience, Amsterdam, The Netherlands.
J Neurol Neurosurg Psychiatry ; 89(1): 89-94, 2018 01.
Article em En | MEDLINE | ID: mdl-28899958
BACKGROUND: Anxiety is a common neuropsychiatric symptom in Parkinson's disease (PD), yet the neural mechanisms have been scarcely investigated. Disturbances in dopaminergic and serotonergic signalling may play a role in its pathophysiology. 123I-N-ω-fluoropropyl-2ß-carbomethoxy-3ß-(4-iodophenyl)nortropane (123I-FP-CIT) is a single-photon emission CT radiotracer, and its binding in striatal and extrastriatal subcortical brain areas represents predominant binding to the presynaptic dopamine transporter (DAT) and the serotonin transporter (SERT), respectively. Availability of DAT and SERT may thus provide an in vivo measure for the integrity of both dopamine and serotonin neurons. METHODS: We studied the association between anxiety symptoms, measured with an affective subscale of the Beck Anxiety Inventory, and (extra)striatal 123I-FP-CIT binding in 127 non-demented patients with PD with a median disease duration of 2.55 (IQR 2.90) years. We conducted the analyses on patients currently on or not on dopamine replacement therapy (DRT). RESULTS: Severity of anxiety symptoms showed a significant negative association with 123I-FP-CIT binding ratios in the right thalamus (ß=-0.203, p=0.019; ΔR2=0.040) (multiple testing pcorr <0.020). In the subgroup of patients not on DRT (n=81), we found a significant negative association between anxiety and thalamic 123I-FP-CIT binding ratios bilaterally (right: ß=-0.349, p=0.001, ΔR2=0.119; left: ß=-0.269, p=0.017, ΔR2=0.071) (pcorr <0.020). CONCLUSION: This study shows that higher levels of anxiety in patients with PD are associated with lower thalamic 123I-FP-CIT binding, pointing towards a contribution of serotonergic degeneration to anxiety symptoms in PD.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Ansiedade / Doença de Parkinson / Encéfalo / Proteínas da Membrana Plasmática de Transporte de Serotonina Tipo de estudo: Diagnostic_studies / Observational_studies / Prevalence_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: J Neurol Neurosurg Psychiatry Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Holanda

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Ansiedade / Doença de Parkinson / Encéfalo / Proteínas da Membrana Plasmática de Transporte de Serotonina Tipo de estudo: Diagnostic_studies / Observational_studies / Prevalence_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: J Neurol Neurosurg Psychiatry Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Holanda